Superantigen
Superantigens (SAgs) are a class of
The large number of activated T-cells generates a massive immune response which is not specific to any particular
Structure
SAgs are produced intracellularly by bacteria and are released upon infection as extracellular mature toxins.[4]
The sequences of these bacterial toxins are relatively conserved among the different subgroups. More important than sequence homology, the 3D structure is very similar among different SAgs resulting in similar functional effects among different groups.[5][6] There are at least 5 groups of superantigens with different binding preferences.[7]
The domains have binding regions for the major histocompatibility complex class II (MHC class II) and the T-cell receptor (TCR), respectively. By bridging these two together, the SAg causes nonspecific activation.[8]
Binding
Superantigens bind first to the MHC class II and then coordinate to the variable
MHC Class II
SAgs show preference for the HLA-DQ form of the molecule.[10] Binding to the α-chain puts the SAg in the appropriate position to coordinate to the TCR.
Less commonly, SAgs attach to the polymorphic MHC class II β-chain in an interaction mediated by a zinc ion coordination complex between three SAg residues and a highly conserved region of the HLA-DR β chain.[6] The use of a zinc ion in binding leads to a higher affinity interaction.[5] Several staphylococcal SAgs are capable of cross-linking MHC molecules by binding to both the α and β chains.[5][6] This mechanism stimulates cytokine expression and release in antigen presenting cells as well as inducing the production of costimulatory molecules that allow the cell to bind to and activate T cells more effectively.[6]
T-cell receptor
T-cell binding region of the SAg interacts with the Variable region on the Beta chain (Vβ region) of the T-cell Receptor. A given SAg can activate a large proportion of the T-cell population because the human T-cell repertoire comprises only about 50 types of Vβ elements and some SAgs are capable of binding to multiple types of Vβ regions. This interaction varies slightly among the different groups of SAgs.
The biological strength of the SAg (its ability to stimulate) is determined by its
T-cell signaling
The SAg cross-links the MHC and the TCR inducing a signaling pathway that results in the
It is hypothesized that Fyn rather than Lck is activated by a tyrosine kinase, leading to the adaptive induction of anergy.[16]
Both the protein kinase C pathway and the protein tyrosine kinase pathways are activated, resulting in upregulating production of proinflammatory cytokines.[17]
This alternative signaling pathway impairs the calcium/calcineurin and Ras/MAPkinase pathways slightly,[16] but allows for a focused inflammatory response.
Effects
Direct effects
SAg stimulation of antigen presenting cells and T-cells elicits a response that is mainly inflammatory, focused on the action of
This excessive uncoordinated release of cytokines, (especially TNF-α), overloads the body and results in rashes, fever, and can lead to multi-organ failure, coma and death.[10][12]
Deletion or
One mechanism by which this is possible involves cytokine-mediated suppression of T-cells. MHC crosslinking also activates a signaling pathway that suppresses
IFN-α is another product of prolonged SAg exposure. This cytokine is closely linked with induction of autoimmunity,[21] and the autoimmune disease Kawasaki disease is known to be caused by SAg infection.[14]
SAg activation in T-cells leads to production of
To summarize, the T-cells are stimulated and produce excess amounts of cytokine resulting in cytokine-mediated suppression of T-cells and deletion of the activated cells as the body returns to homeostasis. The toxic effects of the microbe and SAg also damage tissue and organ systems, a condition known as toxic shock syndrome.[22]
If the initial inflammation is survived, the host cells become anergic or are deleted, resulting in a severely compromised immune system.
Superantigenicity-independent (indirect) effects
Apart from their mitogenic activity, SAgs are able to cause symptoms that are characteristic of infection.[2]
One such effect is
SAgs are able to stimulate recruitment of
One of the more dangerous indirect effects of SAg infection concerns the ability of SAgs to augment the effects of
Diseases associated with superantigen production
- Diabetes mellitus
- Eczema
- Guttate psoriasis
- Kawasaki disease
- Nasal polyps[24]
- Rheumatic fever
- Rheumatoid arthritis
- Scarlet fever[10]
- Toxic shock syndrome
- Infective endocarditis[25]
Treatment
The primary goals of medical treatment are to hemodynamically stabilize the patient and, if present, to eliminate the microbe that is producing the SAgs. This is accomplished through the use of
The body naturally produces
Evolution of superantigen production
SAg production effectively corrupts the immune response, allowing the microbe secreting the SAg to be carried and transmitted unchecked. One mechanism by which this is done is through inducing anergy of the T-cells to antigens and SAgs.
When the structure of individual SAg domains has been compared to other immunoglobulin-binding streptococcal proteins (such as those toxins produced by
"Staphylococcal Superantigen-Like" (SSL) toxins are a group of secreted proteins structurally similar to SAgs. Instead of binding to MHC and TCR, they target diverse components of
Endogenous and viral SAgs
Minor lymphocyte stimulating (Mls; P03319) exotoxins were originally discovered in the
Similar endogenous SAg-dependent selection has yet to be identified in the human genome, but endogenous SAgs have been discovered and are suspected of playing an integral role in viral infection. Infection by the Epstein–Barr virus, for example, is known to cause production of a SAg in infected cells, yet no gene for the toxin has been found on the genome of the virus. The virus manipulates the infected cell to express its own SAg genes, and this helps it to evade the host immune system. Similar results have been found with rabies, cytomegalovirus, and HIV.[2] In 2001, it was found that EBV actually transactivates a superantigen encoded by the env gene (O42043) of HERV-K18. In 2006, it was found that EBV does so by docking to CD2.[31]
The two viral superantigens have no homology to aforementioned bacterial superantigens, nor are they homologous to each other.
References
- ISBN 9781260116717.
- ^ PMID 11944185.
- ^ Li H., Llera A., Malchiodi E.L., Mariuzza R.A. The structural basis of T cell activation by superantigens. Annu. Rev. Immunol. 1999;17:435–466. doi: 10.1146/annurev.immunol.17.1.435.
- PMID 17029999.
- ^ PMID 15049778.
- ^ PMID 7595227.
- PMID 17560120.
- ^ PMID 9514739.
- ^ PMID 7042568.
- ^ PMID 12635926.
- ^ PMID 17303163.
- ^ PMID 16171815.
- PMID 9881971.
- ^ PMID 10860729.
- ^ PMID 17083922.
- ^ PMID 17400472.
- ^ .
- ^ S2CID 6208425.
- PMID 10429670.
- PMID 10608299.
- PMID 11672541.
- ^ PMID 8921429.
- PMID 9645755.
- PMID 15828304.
- ^ Salgado-Pabón W, et al. (2013) Superantigens are critical for Staphylococcus aureus infective endocarditis, sepsis, and acute kidney injury. MBio 4:e00494-00413.
- PMID 14583188.
- PMID 9593304.
- PMID 12028112.
- PMID 22949551.
- PMID 28880913.
- PMID 16887963.
Rasooly, R., Do, P. and Hernlem, B. (2011) Auto-presentation of Staphylococcal enterotoxin A by mouse CD4+ T cells. Open Journal of Immunology, 1, 8-14.
Further reading
- Superantigen Web Database at Birkbeck, University of London
- List of Superantigen Proteins from UniProt
- Superantigens at the U.S. National Library of Medicine Medical Subject Headings (MeSH)
External links
- Media related to Superantigens at Wikimedia Commons